In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine system

Molecular Brain Research

Volumn 137, Issue 1-2, 2005, Pages 1-10

  Torres, E M ^a   Monville, C ^a   Lowenstein, P R ^b   Castro, M G ^b   Dunnett, S B ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

6 OHDA; Adenovirus; Animal model; Gene therapy; Parkinson's disease; Viral vectors

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; DOPAMINE; OXIDOPAMINE; RECOMBINANT ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEGENERATION; BRAIN INJURY; CELL COUNT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DIFFUSION; DOPAMINERGIC SYSTEM; DOSE RESPONSE; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; IN VIVO STUDY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; LAC OPERON; NEURAL PATHWAYS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SYMPATHOLYTICS; TRANSFECTION; TRANSGENES;

ADENOVIRIDAE; ANIMALIA;

EID: 20444372665     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.10.046     Document Type: Article

References (32)

1. S. Akli, C. Caillaud, E. Vigne, L.D. Stratford-Perricaudet, L. Poenaru, M. Perricaudet, A. Kahn, and M.R. Peschanski Transfer of a foreign gene into the brain using adenovirus vectors Nat. Genet. 3 1993 224 228
2. A. Amalfitano, M.A. Hauser, H. Hu, D. Serra, C.R. Begy, and J.S. Chamberlain Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted J. Virol. 72 1998 926 933
3. G. Bajocchi, S.H. Feldman, R.G. Crystal, and A. Mastrangeli Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors Nat. Genet. 3 1993 229 234
4. A. Bilang-Bleuel, F. Revah, P. Colin, I. Locquet, J.J. Robert, J. Mallet, and P. Horellou Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease Proc. Natl. Acad. Sci. U. S. A. 94 1997 8818 8823
5. A. Bjorklund, D. Kirik, C. Rosenblad, B. Georgievska, C. Lundberg, and R.J. Mandel Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model Brain Res. 886 2000 82 98
6. A.P. Byrnes, J.E. Rusby, M.J. Wood, and H.M. Charlton Adenovirus gene transfer causes inflammation in the brain Neuroscience 66 1995 1015 1024
7. A.P. Byrnes, R.E. MacLaren, and H.M. Charlton Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination J. Neurosci. 16 1996 3045 3055
8. X. Chen, W. Liu, Y. Guoyuan, Z. Liu, S. Smith, D.B. Calne, and S. Chen Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson's disease Parkinsonism Relat. Disord. 10 2003 1 7
9. D.L. Choi-Lundberg, Q. Lin, Y.N. Chang, Y.L. Chiang, C.M. Hay, H. Mohajeri, B.L. Davidson, and M.C. Bohn Dopaminergic neurons protected from degeneration by GDNF gene therapy Science 275 1997 838 841
10. D.L. Choi-Lundberg, Q. Lin, T. Schallert, D. Crippens, B.L. Davidson, Y.N. Chang, Y.L. Chiang, J. Qian, L. Bardwaj, and M.C. Bohn Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor Exp. Neurol. 154 1998 261 275
11. F. Cicchetti, A.L. Brownell, K. Williams, Y.I. Chen, E. Livni, and O. Isacson Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging Eur. J. Neurosci. 15 2002 991 998
12. B. Connor, D.A. Kozlowski, J.R. Unnerstall, J.D. Elsworth, J.L. Tillerson, T. Schallert, and M.C. Bohn Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration Exp. Neurol. 169 2001 83 95
13. B.L. Davidson, and M.C. Bohn Recombinant adenovirus: a gene transfer vector for study and treatment of CNS diseases Exp. Neurol. 144 1997 125 130
14. B.L. Davidson, E.D. Allen, K.F. Kozarsky, J.M. Wilson, and B.J. Roessler A model system for in vivo gene transfer into the central nervous system using an adenoviral vector Nat. Genet. 3 1993 219 223
15. R.A. Dewey, G. Morrissey, C.M. Cowskill, D. Stone, F. Bolognani, N.J. Dodd, T.D. Southgate, D. Klatzmann, H. Lassmann, M.G. Castro, and P.R. Lowenstein Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials Nat. Med. 5 11 1999 1256 1263
16. N.A. Do Thi, P. Saillour, L. Ferrero, J.F. Dedieu, J. Mallet, and T. Paunio Delivery of GDNF by an E1, E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease 1 Gene Ther. 11 2004 746 756
17. J.F. Hamilton, P.F. Morrison, M.Y. Chen, J. Harvey-White, R.S. Pernaute, H. Phillips, E. Oldfield, and K.S. Bankiewicz Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin Exp. Neurol. 168 1 2001 155 161
18. K. Jooss, and N. Chirmule Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy Gene Ther. 10 2003 955 963
19. S. Kochanek High-capacity adenoviral vectors for gene transfer and somatic gene therapy Hum. Gene Ther. 10 1999 2451 2459
20. S. Kochanek, G. Schiedner, and C. Volpers High-capacity 'gutless' adenoviral vectors Curr. Opin. Mol. Ther. 3 2001 454 463
21. J.H. Kordower, M.E. Emborg, J. Bloch, S.Y. Ma, Y. Chu, L. Leventhal, J. McBride, E.Y. Chen, S. Palfi, B.Z. Roitberg, W.D. Brown, J.E. Holden, R. Pyzalski, M.D. Taylor, P. Carvey, Z. Ling, D. Trono, P. Hantraye, N. Deglon, and P. Aebischer Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease Science 290 2000 767 773
22. A.I. Kuzmin, O. Galenko, and R.C. Eisensmith An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors Mol. Ther. 3 2001 293 301
23. P.A. Lapchak, D.M. Araujo, D.C. Hilt, J. Sheng, and S. Jiao Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease Brain Res. 777 1997 153 160
24. M.S. Lawrence, H.G. Foellmer, J.D. Elsworth, J.H. Kim, C. Leranth, D.A. Kozlowski, A.L. Bothwell, B.L. Davidson, M.C. Bohn, and D.E. Redmond Jr. Inflammatory responses and their impact on beta-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus Gene Ther. 6 1999 1368 1379
25. L.S. Le Gal, J.J. Robert, S. Berrard, V. Ridoux, L.D. Stratford-Perricaudet, M. Perricaudet, and J. Mallet An adenovirus vector for gene transfer into neurons and glia in the brain Science 259 1993 988 990
26. G.M. Pasinetti, M. Hassler, D. Stone, and C.E. Finch Glial gene expression during aging in rat striatum and in long-term responses to 6-OHDA lesions Synapse 31 4 1999 278 285
27. P. Rataboul, P. Vernier, N.F. Biguet, J. Mallet, P. Poulat, and A. Privat Modulation of GFAP mRNA levels following toxic lesions in the basal ganglia of the rat Brain Res. Bull. 22 1 1989 155 161
28. I. Stromberg, H. Bjorklund, D. Dahl, G. Jonsson, E. Sundstrom, and L. Olson Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry Brain Res. Bull. 17 2 1986 225 236
29. C.E. Thomas, D. Birkett, I. Anozie, M.G. Castro, and P.R. Lowenstein Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain Mol. Ther. 3 2001 36 46
30. U. Ungerstedt Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system Acta Physiol. Scand. Suppl. 367 1971 69 93
31. M.J. Wood, H.M. Charlton, K.J. Wood, K. Kajiwara, and A.P. Byrnes Immune responses to adenovirus vectors in the nervous system Trends Neurosci. 19 1996 497 501
32. Y. Yang, F.A. Nunes, K. Berencsi, E.E. Furth, E. Gonczol, and J.M. Wilson Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy Proc. Natl. Acad. Sci. U. S. A. 91 1994 4407 4411